Alignment Healthcare, Inc.
ALHC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.10 | 2.25 | 0.52 | -0.01 |
| FCF Yield | -0.31% | -5.94% | -3.25% | -4.02% |
| EV / EBITDA | -26.38 | -14.92 | -16.61 | -13.03 |
| Quality | ||||
| ROIC | -23.54% | -38.86% | -31.92% | -38.41% |
| Gross Margin | 10.97% | 11.02% | 12.85% | 11.02% |
| Cash Conversion Ratio | -0.27 | 0.40 | 0.30 | 0.40 |
| Growth | ||||
| Revenue 3-Year CAGR | 23.53% | 16.02% | 14.35% | 15.55% |
| Free Cash Flow Growth | 93.02% | -37.54% | 28.76% | -1,092.29% |
| Safety | ||||
| Net Debt / EBITDA | 1.34 | 0.31 | 2.16 | 1.91 |
| Interest Coverage | -4.31 | -6.02 | -7.03 | -10.21 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -16.00 | -14.29 | -26.56 | 12.17 |